New use for the treatment of gastroesophageal reflux disease

Details New use for the treatment of gastroesophageal reflux disease New use for the treatment of gastroesophageal reflux disease

A - Human Necessities

61

K

A61K 31/05 (2006.01) A61K 31/00 (2006.01) A61K 31/16 (2006.01) A61K 31/352 (2006.01) A61K 31/403 (2006.01) A61K 31/5375 (2006.01) A61K 31/538 (2006.01) A61K 31/557 (2006.01) A61P 21/00 (2006.01)

Patent

CA 2466916

The present invention relates to the use of cannabinoid receptor agonists for the inhibition of transient lower esophageal sphincter relaxations. A further aspect of the invention is directed to the use of cannabinoid receptor agonists for the treatment of gastroesophageal reflux disease, as well as for the treatment of regurgitation such as regurgitation in infants, lung disease, chronic laryngitis and asthma.

La présente invention concerne l'utilisation d'agonistes du récepteur cannabinoïde pour l'inhibition de relaxations transitoires du sphincter oesophagien inférieur. La présente invention concerne également l'utilisation d'agonistes du récepteur cannabinoïde pour le traitement du reflux gastro- oesophagien, de la régurgitation, de la régurgitation chez l'enfant, de maladies pulmonaires, de laryngites chroniques et de l'asthme.

Affiliated with

Also associated with

Rating

New use for the treatment of gastroesophageal reflux disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New use for the treatment of gastroesophageal reflux disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New use for the treatment of gastroesophageal reflux disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1382483